Compare IONQ & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IONQ | ICLR |
|---|---|---|
| Founded | 2015 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Wholesale Distributors | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9B | 13.1B |
| IPO Year | 2020 | 2001 |
| Metric | IONQ | ICLR |
|---|---|---|
| Price | $43.37 | $165.86 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 18 |
| Target Price | $66.63 | ★ $185.82 |
| AVG Volume (30 Days) | ★ 20.7M | 1.0M |
| Earning Date | 11-04-2026 | 10-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,235,000,000.00 | N/A |
| Revenue This Year | $250.04 | N/A |
| Revenue Next Year | $78.95 | $3.69 |
| P/E Ratio | ★ N/A | $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $25.89 | $66.57 |
| 52 Week High | $84.64 | $203.91 |
| Indicator | IONQ | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 55.30 | 48.23 |
| Support Level | $39.77 | $162.32 |
| Resistance Level | $44.43 | $180.07 |
| Average True Range (ATR) | 2.28 | 6.35 |
| MACD | 0.49 | -0.45 |
| Stochastic Oscillator | 60.47 | 31.51 |
IonQ Inc sells access to several quantum computers of various qubit capacities and is in the process of researching and developing technologies for quantum computers with increasing computational capabilities. The company currently makes access to its quantum computers available via cloud platforms and also to select customers via its own cloud service. This cloud-based approach enables the broad availability of quantum-computing-as-a-service (QCaaS). The company derives its revenue from its quantum-computing-as-a-service arrangements, consulting services related to co-developing algorithms on company's quantum computing systems and contracts associated with the design, development, and construction of specialized quantum computing systems together with related services.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.